WebDisclosure WebDisclosure
Basculer en Français
10883 Companies
236792 Keywords
165665 Articles
127031 Press releases
Headlines Articles Press releases Xcyte Digital Corp. Remove
  1. Home
  2. Companies
  3. Xcyte Digital Corp.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 11/10/2023 at 00:25, 2 years 9 months ago

    Xcyte Digital Announces Closing of Qualifying Transaction and Concurrent Financing

    Logo of Xcyte Digital Corp.
  • PRESS RELEASE

    published on 11/02/2023 at 23:10, 2 years 9 months ago

    GHP Noetic Science-Psychedelic Pharma Announces TSXV Conditional Approval of Proposed Qualifying Transaction

    Logo of Xcyte Digital Corp.
  • PRESS RELEASE

    published on 07/28/2023 at 22:40, 3 years ago

    GHP Noetic Science-Psychedelic Pharma Inc. Provides Update on Qualifying Transaction With Xcyte Digital Corp.

    Logo of Xcyte Digital Corp.
  • PRESS RELEASE

    published on 06/22/2023 at 22:35, 3 years 2 months ago

    GHP Noetic Science-Psychedelic Pharma Inc. and Xcyte Digital Corp. Proposed Qualifying Transaction

    Logo of Xcyte Digital Corp.
  • PRESS RELEASE

    published on 02/09/2023 at 19:00, 3 years 6 months ago

    GHP Noetic Science-Psychedelic Pharma Inc. and Xcyte Digital Corp. Proposed Qualifying Transaction

    Logo of Xcyte Digital Corp.
Previous page
1 2 3
Accesswire
  • Published on 08/26/2026 at 09:05, 36 minutes ago

    BioNxt Advances Cladribine Clinical Program for MS with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies

  • Published on 08/25/2026 at 23:05, 10 hours 36 minutes ago

    Faraday Copper Shareholders Approve Share Issuance in Connection with the Acquisition of the San Manuel Project

  • Published on 08/25/2026 at 22:30, 11 hours 11 minutes ago

    Route1 Reports Q2 2026 Results

  • Published on 08/25/2026 at 15:00, 18 hours 41 minutes ago

    Four Nines Gold Intersects Hydrothermal Breccia in First Three Holes at Hayden Hill

  • Published on 08/25/2026 at 14:30, 19 hours 11 minutes ago

    First Breach Completes First Flight of Drone Prototype and Advances American-Made Manufacturing Through Hellbender Agreement

View all ACCESSWIRE
EQS Group
  • Published on 08/26/2026 at 09:08, 33 minutes ago

    Private Assets combines Kieler Maschinenwerke and Pro-Valve into Kiel Power Systems SE

  • Published on 08/26/2026 at 09:05, 36 minutes ago

    ROHM Introduces 650V IGBTs, Achieving Industry-leading Low-loss Characteristics

  • Published on 08/26/2026 at 09:00, 41 minutes ago

    Original-Research: Emerald Horizon AG (von NuWays AG): BUY

  • Published on 08/26/2026 at 09:00, 41 minutes ago

    Official List Notice

  • Published on 08/26/2026 at 08:05, 1 hour 36 minutes ago

    Sylvox to Showcase All-Season Outdoor Entertainment Across Three Experience Zones at IFA 2026

View all EQS
Les Echos
  • Published on 08/25/2026 at 17:45, 15 hours 56 minutes ago

    DECLARATION D’ACTIONS ET DE DROITS DE VOTE

  • Published on 08/25/2026 at 17:45, 15 hours 56 minutes ago

    CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 08/25/2026 at 17:45, 15 hours 56 minutes ago

    Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026

  • Published on 08/25/2026 at 17:45, 15 hours 56 minutes ago

    Imerys-08-2026-communique-capital-droits-de-vote-au-31-juilet-2026

  • Published on 08/25/2026 at 08:30, 1 day 1 hour ago

    Eiffage wins several contracts worth a total of €132 million in the healthcare sector

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy